Combivent respimat 20-100 MCG 4GM
Ended Awarded
- Contract number
- SPE2DR26FXM4S
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,179
Award facts
- Contract value 100% obligated
- $1,179.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $1,179 delivery order to AmerisourceBergen Drug Corp on June 17, 2026, for Combivent Respimat inhalant medication (20–100 microgram, 4-gram canister).
Place of performance is Conshohocken, PA. Ultimate completion date is June 18, 2026. This is a firm fixed-price order with no set-aside.
Quick answers
Who was awarded contract SPE2DR26FXM4S?
SPE2DR26FXM4S was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 17, 2026.
How much is contract SPE2DR26FXM4S worth?
The government has obligated $1,179 on SPE2DR26FXM4S.
Is contract SPE2DR26FXM4S an order under another contract?
Yes. SPE2DR26FXM4S is a delivery order under SPE2DR25D6037, an indefinite delivery contract.
Was contract SPE2DR26FXM4S competed?
The extent of competition for SPE2DR26FXM4S was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award